Other Events. As previously reported on April 21, 2026, Change Agents Corporation’s (the “Company”) subsidiary, Avalon Quantum AI, LLC, entered into a collaboration with Amazon Web Services (“AWS”) to support Phase 2 development of the Company’s catch-up agentic AI video platform (the “Project”) and to appoint Caylent, Inc., an AWS Premier Tier Consulting Partner and a member of the AWS Generative AI Innovation Center’s Partner Innovation Alliance, to lead the development. AWS agreed to provi…

Unregistered Sales of Equity Securities. The information set forth under

Entry into a Material Definitive Agreement. Amendment to Equity Purchase Agreement for Equity Line On August 21, 2026, Change Agents Corporation (the “Company”) entered into a First Amendment (the “Amendment”) to that certain Equity Purchase Agreement dated July 22, 2026, between the Company and Hudson Global Ventures, LLC, a Nevada limited liability company (the “Investor”). The Amendment amended the terms of the Purchase Agreement pursuant to which the Company may, upon the terms and subjec…

The Pre-Funded Warrant and the shares issuable upon exercise of the Pre-Funded Warrant have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws and were offered and sold, or will be issued, in reliance upon exemptions from the registration requirements of the Securities Act, including Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws. - 1 -

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under

Entry into a Material Definitive Agreement. On August 14, 2026, the Company issued promissory notes to certain accredited investors in the aggregate principal amount of $616,000 (inclusive of a $66,000 original issuance discount) (the “August 2026 OID Notes”) for gross proceeds of $550,000. The Company the net proceeds of the August 2026 OID Notes to repay (i) $144,000 under that certain 7% promissory note in the original principal amount of $233,910 issued to Vanquish Funding Group Inc.(ii)…

Unregistered Sales of Equity Securities. From July 30, 2026 through August 1, 2026, Change Agents Corporation (the “Company”) entered into amendments and addendums to certain outstanding consulting agreements under which the Company agreed to issue an aggregate of 1,550,000 shares of its common stock in consideration of services rendered. These shares were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended. - 1 - SIGNATU…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under

Entry into a Material Definitive Agreement. Business Loan and Security Agreement On July 24, 2026, the Company entered into a Business Loan and Security Agreement (the “Business Loan Agreement”) with a commercial funding source (the “Lender”), pursuant to which the Company obtained a loan from the Lender in the principal amount of $825,000 (the “Business Loan”), with net proceeds to the Company of $254,350, following the payment of an administration fee $41,500 and repayment in full of the pr…

The Commitment Shares were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended. - 1 -

Entry into a Material Definitive Agreement. Equity Line On July 22, 2026, the Change Agents Corporation (the “Company”) entered into an Equity Purchase Agreement (the “Purchase Agreement”) with Hudson Global Ventures, LLC, a Nevada limited liability company (the “Investor”). Pursuant to the Purchase Agreement, upon the terms and subject to the conditions set forth therein, the Company may, from time to time during the Commitment Period, in its sole discretion, require the Investor to purchase…

The Warrant and the shares issuable upon exercise of the Warrant have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws and were offered and sold, or will be issued, in reliance upon exemptions from the registration requirements of the Securities Act, including Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws.

by reference. The shares of Series F Preferred Stock, the shares issuable upon conversion of the Series F Preferred Stock and the Commitment Shares have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any state, and are being offered and sold in reliance on the exemption from registration under the Securities Act, afforded by Section 4(a)(2) and/or Rule 506 promulgated thereunder. On June 29, 2026, the Company issued 150,000 r…

The filing describes the issuance of stock options to officers and non-employee directors as part of a compensatory arrangement.

Entry into a Material Definitive Agreement. On June 30, 2026, Avalon GloboCare Corp., a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with Allen O. Cage Jr., an individual accredited investor (the “Investor”), pursuant to which the Company agreed to issue and sell to the Investor (i) 400 shares of the Company's Series F Convertible Preferred Stock, par value $0.0001 per share (the "Series F Preferred Stock"), having a stated value…

Entry into a Material Definitive Agreement. On June 1, 2026 (the “Dune Issue Date”), Avalon Globocare Corp. (the “Company”) issued promissory note to Dune Equity Holdings LLC (“Dune”) in the principal amount of $250,000 (inclusive of a $50,000 original issuance discount) (the “Dune Note”) for gross proceeds of $200,000. The Company intends to use the net proceeds of the Dune Note for working capital and general corporate purposes. The Dune Note matures on December 1, 20256 and has a one-time…

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth under

Chief Strategy Officer — Luisa Ingargiola: Ms. Ingargiola was promoted to Chief Strategy Officer.

Other Events. On April 21, 2026, the Company issued a press release announcing the collaboration between the Company’s subsidiary, Avalon Quantum AI LLC, and Amazon Web Services (AWS) to support Phase 2 development of its Catch-Up agentic AI video platform, and the appointment of Caylent, Inc., an AWS Premier Tier Consulting Partner and a member of the AWS Generative AI Innovation Center’s Partner Innovation Alliance, to lead the development. AWS has agreed to provide $125,000 of funding in c…

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 15, 2026, Avalon GloboCare Corp. (the “Company”) was notified (the “Notification Letter”) by The Nasdaq Stock Market, LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price…

No proceeds were received upon exercise. These shares were issued pursuant to the exemption from registration provided by Section 4(a)(2) and/or 3(a)(9) of the Securities Act of 1933, as amended.

Other Events. On February 26, 2026, the Company issued a press release announcing the pricing of the Private Placement. A copy this press release is furnished and is incorporated herein by reference. On February 27, 2026, the Company issued a press release announcing the closing of the Private Placement. A copy this press release is furnished and is incorporated herein by reference.

Entry into a Material Definitive Agreement. On February 26, 2026, Avalon GloboCare Corp. (the “ Company ”) entered into securities purchase agreements (the “ Purchase Agreements ”) with certain institutional investors (“the “ Purchasers ”) for the issuance and sale in a private placement (the “ Private Placement ”) of (i) 490,197 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per shares (“ Common Stock ”) at a purchase price of $0.51 per Share; (ii) pre-funded warrants…

The filing details compensatory arrangements for existing officers and directors.

Entry into a Material Definitive Agreement. On February 26, 2026, Avalon GloboCare Corp. (the “ Company ”) entered into securities purchase agreements (the “ Purchase Agreements ”) with certain institutional investors (“the “ Purchasers ”) for the issuance and sale in a private placement (the “ Private Placement ”) of (i) 490,197 shares (the “Shares”) of the Company’s common stock, par value $0.0001 per shares (“ Common Stock ”) at a purchase price of $0.51 per Share; (ii) pre-funded warrants…